Shopping Cart
- Remove All
- Your shopping cart is currently empty
PF-3882845 is an orally available and selective salicorticoid receptor (MR) antagonist that binds to the progesterone receptor (PR) and can be used to study endocrine diseases and urogenital disorders.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $85 | In Stock | |
5 mg | $198 | In Stock | |
10 mg | $293 | In Stock | |
25 mg | $497 | In Stock | |
50 mg | $831 | In Stock |
Description | PF-3882845 is an orally available and selective salicorticoid receptor (MR) antagonist that binds to the progesterone receptor (PR) and can be used to study endocrine diseases and urogenital disorders. |
Targets&IC50 | progesterone receptor:310 nM, mineralocorticoid receptor:2.7 nM |
In vivo | In male Sprague-Dawley rats, PF-3882845 exhibited moderate bioavailability (F 86%) after oral administration (2 mg/kg). When administered intravenously (2 mg/kg), PF-3882845 exhibited a shorter terminal elimination half-life (T1/2 1.7 hours), which was associated with its higher plasma clearance (CL 9.8 mL/min/kg) and larger volume of distribution (Vdss 1.4 mL/kg). PF-3882845 has hypotensive, urinary albumin-reducing and renoprotective effects in Dahl SS rats. [1] |
Alias | PF3882845 |
Molecular Weight | 419.9 |
Formula | C24H22ClN3O2 |
Cas No. | 1023650-66-9 |
Smiles | ClC=1C=C(N2[C@H]([C@@]3(C(=N2)C=4C(CC3)=CC(C(O)=O)=CC4)[H])C5CCCC5)C=CC1C#N |
Relative Density. | no data available |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 8 mg/mL (19.05 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.